Nominate a colleague by May 31 for the William L. McGuire Award, which honors an investigator whose sustained achievements in translational/clinical research have advanced our understanding of the pathogenesis or outcome of breast cancer patients. bit.ly/4dHk30r #SABCS24

Join ⁦Aditya Bardia, MD⁩ ⁦VIRGINIA KAKLAMANI⁩ and I 6/1 for dinner and lively discussion on novel therapies for HR+ MBC. Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs | CCO clinicaloptions.com/events/serds-f…

Significant OS benefit of pembro. Now questions are: do we need that much chemo; do we need adj pembro after pCR; is there signature of response; what do we do with T1c? Great discussion below. SABCS Sara Tolaney Kate Lathrop #sabcssnippets

On a day like today Chicago for me is the most beautiful city in the US. Looking forward to #asco24 UT Health San Antonio MD Anderson

Natalee data in node neg showing 3% benefit of ribo but to me the DDFS difference in events is impressive #asco24.

So proud of Ranjit Banwait, MD, M.Sc for his ASCO Merit award. Angiogenesis is a forgotten pathway in the US but definitely an important one. Biomarker signature is key.

Great review by ⁦Ruth O'Regan⁩ on ET in MBC. Inavo in ET resistance shows benefit; no role for chemo in 1st line setting; sequencing cdks can produce benefit but based on other available options may have to be selective in its use. #asco24

Wonderful to see our junior colleagues have oral presentations. Sara Tolaney this doesn’t go unnoticed. #ASCO24

Honored to participate in an ASCO OncLive.com Peer Direct panel on Advances in HR+ HER2- mBC with my esteemed colleagues Drs Hurvitz, Pegram and VIRGINIA KAKLAMANI. Go to OncLive.com to see our finished production. Thank you to organizers for the opportunity!

Fellow graduation last night. What an amazing group of physicians who will help change the world. So proud of them. Kate Lathrop Marcela Mazo UT Health San Antonio MD Anderson

#sabcssnippets on highlights from #ASCO24 Thank you William Gradishar, MD Heather McArthur, MD, MPH and Aditya Bardia, MD for contributing your thoughts SABCS UT Health San Antonio MD Anderson youtu.be/7qGniRrl2BE

Had the honor to know him during my training. Worked in the lab next door. Was always a treat to talk science with him. #bcsm Lurie Cancer Center mdanderson.org/newsroom/md-an…

Great initiative to speed up progress in ILC. #bcsm

With Dr Seema Khan comparing the nccn and Chinese guidelines in breast cancer care. Always humbling to hear views from our Chinese colleagues #bcsm UT Health San Antonio MD Anderson Lurie Cancer Center

Just published online. Very proud of this work. Aditya Bardia, MD UT Health San Antonio MD Anderson aacrjournals.org/clincancerres/…

Podcasts on role of GnRH agonists in early stage BC Ann Partridge MD, MPH medlearninggroup.com/cme-programmin… #bcsm

Never gets old #Athens

New ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history

Received this in the mail last week and I am thrilled to announce that #October15 is officially recognized as #Lobular #BreastCancer Awareness Day in the great state of #Texas! 🎉 We’re hosting a celebration MD Anderson Cancer Center to mark this incredible milestone. Special thanks to

Capitello 290 neg trial but was the primary endpoint really the right endpoint? Heather McArthur, MD, MPH ESMO - Eur. Oncology #bcsm